Cover image of The Readout Loud
(149)
Business

The Readout Loud

Updated 9 days ago

Business
Read more

Podcast by STAT

Read more

Podcast by STAT

iTunes Ratings

149 Ratings
Average Ratings
127
12
4
3
3

Good, Quick Catchup

By orange-juicer - Mar 26 2020
Read more
Thanks for the stories and interviews! Well-researched and balanced reporting.

My favorite podcast!

By Tinatttt - Jan 15 2020
Read more
Love being able to catch up on the road. Best I could find. Thank you!

iTunes Ratings

149 Ratings
Average Ratings
127
12
4
3
3

Good, Quick Catchup

By orange-juicer - Mar 26 2020
Read more
Thanks for the stories and interviews! Well-researched and balanced reporting.

My favorite podcast!

By Tinatttt - Jan 15 2020
Read more
Love being able to catch up on the road. Best I could find. Thank you!
Cover image of The Readout Loud

The Readout Loud

Latest release on Apr 02, 2020

Read more

Podcast by STAT

Rank #1: Episode 85: Every angle on Biogen's shocking Alzheimer's news

Podcast cover
Read more
What exactly is Biogen doing? When is a press release worth $12 billion? And what should patients make of whiplashing news? We're devoting this entire episode to Biogen's stunning announcement that aducanumab, its once-discarded treatment for Alzheimer's disease, is getting a second life.

Oct 24 2019

28mins

Play

Rank #2: Episode 53: How startups stop, the new FDA boss, and Theranos on the big screen

Podcast cover
Read more
Who deserves credit for a new gene therapy? How do you push stop on a startup? And what does MC Hammer have to do with Theranos?

Mar 14 2019

31mins

Play

Rank #3: Episode 43: A people's history of J.P. Morgan

Podcast cover
Read more
Do drug developers tip well? Is biotech safe for 6-year-olds? And what's a Cable Car Cosmo?

Jan 10 2019

14mins

Play

Rank #4: Episode 69: The future of AbbVieGan, the dogma of amyloid, & some questionable biotech marketing

Podcast cover
Read more
Can Botox make Big Pharma attractive? What qualifies as a "cabal"? And will the CRISPR patent fight outlive us all?

Jun 27 2019

25mins

Play

Rank #5: Episode 60: Boardroom drama, whiskey-fueled science, & millionaires on mushrooms

Podcast cover
Read more
Is Biogen bracing for a fight? What does Jack Daniels have to do with immunotherapy? And will "micro-dosing" light the way to actual therapies?

May 02 2019

22mins

Play

Rank #6: Episode 74: Novartis and the no good, very bad week

Podcast cover
Read more
Why did Novartis (NVS) keep its scandal to itself? Who knew what and when? And is there such thing as too much Peloton time?

Aug 08 2019

19mins

Play

Rank #7: Episode 76: Sarepta keeps a secret, an online army mobilizes, & China embraces biotech

Podcast cover
Read more
How should you talk to friends about rejection? Can Facebook actually improve the lives of children? And how's biotech doing in China?

Aug 22 2019

23mins

Play

Rank #8: Episode 48: The AI hype machine, ketamine's future, and the rocky path ahead for NASH

Podcast cover
Read more
When will AI replace your radiologist? What can pharma learn from ketamine? And is liver disease more complicated than anyone thought?

Feb 14 2019

23mins

Play

Rank #9: Episode 61: Pharma felonies, cardiac CRISPR, and a strange day at the FDA

Podcast cover
Read more
Are law-breaking pharma executives the new mob bosses? Can genome editing preventing heart attacks? And can the FDA regulate drug prices?

May 09 2019

25mins

Play

Rank #10: Episode 84: CRISPR with Netflix filmmakers, Pharma's future in China & where VC dollars come from

Podcast cover
Read more
Should drug companies be free-speech advocates? Is your retirement dependent on CRISPR? And how useful is a glow-in-the-dark dog?

Oct 17 2019

26mins

Play

Rank #11: Episode 55: The fate of Bristol-Myers-Celgene, the tragedy of SIDS, and health tech's challenges

Podcast cover
Read more
Why can't investors think for themselves? How do parents cope with inexplicable tragedy? And is tech prepared for the toughest parts of health care?

Mar 28 2019

26mins

Play

Rank #12: Episode 46: Another Alzheimer's setback, crypto for biotech, and a blessing of unicorns

Podcast cover
Read more
Is the drug industry wrong about Alzheimer's disease? Can cryptocurrency fund actual science? And should you feel sorry for Big Pharma?

Jan 31 2019

24mins

Play

Rank #13: Episode 51: CEOs at the Senate, merger mania, and sleuthing startups

Podcast cover
Read more
Is this the age of the big biotech buyout? Is cold brew a business expense? And how do you pronounce "Gonzalez"?

Feb 28 2019

26mins

Play

Rank #14: Episode 72: Vertex's regime change, the return of Ebola, & the rise of digital health

Podcast cover
Read more
What makes an epidemic newsworthy? Can biotech succession succeed? And what's so novel about digital health?

Jul 25 2019

26mins

Play

Rank #15: Episode 63: Your ASCO preview, genetic whiplash, and a journalist's experience with cancer

Podcast cover
Read more
What should you watch for at the year's biggest cancer conference? Why are people having 23andMe-induced identity crises? And what's it like to be at once a journalist and a cancer patient?

May 23 2019

31mins

Play

Rank #16: Episode 65: A special episode from the halls of the ASCO meeting

Podcast cover
Read more
What can be done to improve HPV vaccination rates in the U.S.? How does the genetic signature of a tumor lead to an effective cancer drug? What’s it like being a doctor and a cancer patient?

Jun 04 2019

29mins

Play

Rank #17: Episode 59: When scientists get mad online, for-profit cancer care, & the perils of naming a startup

Podcast cover
Read more
Who gets to be "influential"? Should you be skeptical of for-profit hospitals? And should George Lucas fire his attorneys?

Apr 25 2019

22mins

Play

Rank #18: Episode 49: Painkiller racketeering, the limits of genetic tests, and pharma's day on the Hill

Podcast cover
Read more
Is pharma about to have its Big Tobacco moment? Are we overestimating human genetics? And can sales reps rap?

We discuss all that and more on the latest episode of “The Readout LOUD,” STAT’s biotech podcast. First, Boston Globe reporter Jonathan Saltzman joins us to discuss the case against Insys Therapeutics, the maker of a powerful painkiller now accused of running a nationwide racketeering scheme. Then Dr. Laura Esserman of the University of California, San Francisco, comes on to break down the debate over genetic testing for cancer risk. And then we give you the need-to-know on an upcoming Senate hearing that will see seven pharma executives get grilled on the rising cost of medicines in the U.S.

Feb 21 2019

23mins

Play

Rank #19: Episode 92: The decade in breakthroughs, the year in bad CEOs, and the viruses that cure disease

Podcast cover
Read more
Which drug defined the decade? Who's the worst CEO in biopharma? And how does gene therapy actually work?

Dec 19 2019

24mins

Play

Rank #20: Episode 88: Dr. David Sable on an alarming genetic test & Jorge Conde on the perils of bio-Twitter

Podcast cover
Read more
Do you trust Google with your health data? Is "Gattaca" an outdated reference? And what's it like to get dunked on?

Nov 14 2019

25mins

Play

Episode 105: Pandemic exit strategies, how the outbreak affects patients, and Ken Burns takes on DNA

Podcast cover
Read more
When will things go back to normal? What if a pandemic strikes when you're already sick? And what does Ken Burns know about genomics?

Apr 02 2020

23mins

Play

Episode 104: Fauci's star turn, the latest on coronavirus, and an under-the-radar Alzheimer's drug

Podcast cover
Read more
When can we stop distancing? Does the "deep state" meet over Zoom? And could the amyloid hypothesis come through at last?

Mar 26 2020

28mins

Play

Episode 103: Trump's coronavirus pivot, life inside the ICU & drug development in a pandemic

Podcast cover
Read more
Why did the U.S. change its tune on coronavirus? What's it like to be an ICU nurse right now? And when are we getting a vaccine?

Mar 19 2020

25mins

Play

Episode 102: Voices from the coronavirus pandemic, in Italy, New York, and the high seas

Podcast cover
Read more
How long will this pandemic persist? Are U.S. hospitals going to be overwhelmed? And what’s it like to be quarantined on a cruise ship?

Mar 12 2020

25mins

Play

Episode 101: Pharma’s response to coronavirus, Google's appetite for health data, & biotech in China

Podcast cover
Read more
Does “The Art of the Deal” cover vaccines? Is patient privacy a relic of the past? And how big can biotech get in China?

Mar 05 2020

28mins

Play

Episode 100: Wall Street's coronavirus freakout, clinical trial difficulties, and a look back

Podcast cover
Read more
Is the market overreacting to the coronavirus? Why do so many clinical trials go unfilled? And how do you pronounce "Martin Shkreli"?

Feb 27 2020

28mins

Play

Episode 99: Genetic medicine w/ Ethan Weiss, drug industry infighting, & a microbiome review

Podcast cover
Read more
Can biopharma police itself? Who decides whether something's a disease or a difference? And will fecal matter ever become a drug?

Feb 20 2020

29mins

Play

Episode 98: Les Funtleyder on biotech investing; the Zolgensma lottery & billionaire philanthropy

Podcast cover
Read more
What's the right way to give drugs away? Is $3 billion even a lot of money? And when is biotech hype justified?

Feb 13 2020

24mins

Play

Episode 97: Fake outbreak news, treating coronavirus, and biotech's Mount Rushmore

Podcast cover
Read more
Is peer review underrated? Can biotech stop an outbreak? And would you mind giving us a call?

We're coming up on the 100th episode of this podcast, and we're using the occasion to actualize our long-held dream of running a call-in show. Dial us at 617-517-6130 and leave a message with any question you'd like us to answer on the podcast, and you may just hear it on air in the coming weeks.

Feb 06 2020

23mins

Play

Episode 96: A chemist breaks bad, the latest on the coronavirus, and pharma’s slow Bern

Podcast cover
Read more
Is it wise to lie to the feds? Is pharma taking Sen. Bernie Sanders seriously? And what constitutes a "public health emergency of international concern?"

Jan 30 2020

26mins

Play

Episode 95: The latest on the China virus, Sarepta's ongoing FDA saga, and biotech at Davos

Podcast cover
Read more
Are we dealing with a SARS redux? Has the FDA lost its teeth? And what do billionaires talk to each other about?

Jan 23 2020

22mins

Play

Episode 94: EQRx's Alexis Borisy, Stephen Buck on his website for cancer patients, and a JPM recap

Podcast cover
Read more
Why weren't there any big deals announced this week? What does the word "equivalar" mean? And why is information about prognosis so hard to find?

Jan 16 2020

23mins

Play

Episode 93: Josiah Zayner on getting canceled, good news in cancer, an Ebola vaccine saga

Podcast cover
Read more
Does pharma deserve more credit? Will history forgive He Jiankui? And how does a laboratory eureka become a lifesaving vaccine?

Jan 09 2020

26mins

Play

Episode 92: The decade in breakthroughs, the year in bad CEOs, and the viruses that cure disease

Podcast cover
Read more
Which drug defined the decade? Who's the worst CEO in biopharma? And how does gene therapy actually work?

Dec 19 2019

24mins

Play

Episode 91: CAR-T's future, an alarming cancer trend & Chris Garabedian on Sarepta's FDA legacy

Podcast cover
Read more
Has CAR-T lost its luster? Why is colorectal cancer on the rise? And did the FDA forever change in 2016?

Dec 12 2019

25mins

Play

Episode 90: Biogen's big reveal, hot takes on Alzheimer's, & the science of one-eyed sheep

Podcast cover
Read more
How do you know if a "positive" study is positive? And how did one-eyed sheep lead to a drug for certain cancers?

Dec 05 2019

24mins

Play

Episode 89: Warren's awkward home front, a dwarfism drug, and the sound of STAT Summit

Podcast cover
Read more
Can Sen. Elizabeth Warren ever go home again? Is it ethical to make little people taller? And when will AI come up with a new drug?

Nov 22 2019

24mins

Play

Episode 88: Dr. David Sable on an alarming genetic test & Jorge Conde on the perils of bio-Twitter

Podcast cover
Read more
Do you trust Google with your health data? Is "Gattaca" an outdated reference? And what's it like to get dunked on?

Nov 14 2019

25mins

Play

Episode 87: Derek Lowe on China's new Alzheimer's drug, blockbuster fish oil, & STAT's birthday

Podcast cover
Read more
Why hope for China's new Alzheimer's drug turned into skepticism ? Is three a crowd in CAR-T? And what's a Bionomy?

Nov 07 2019

20mins

Play

Episode 86: Drugs that don't work, wearables in the desert, & excess 'innovation'

Podcast cover
Read more
When should a drug be pulled from shelves? How do you pronounce "HLTH?" And how does Ann Coulter decide what to tweet?

Oct 31 2019

28mins

Play

iTunes Ratings

149 Ratings
Average Ratings
127
12
4
3
3

Good, Quick Catchup

By orange-juicer - Mar 26 2020
Read more
Thanks for the stories and interviews! Well-researched and balanced reporting.

My favorite podcast!

By Tinatttt - Jan 15 2020
Read more
Love being able to catch up on the road. Best I could find. Thank you!